Campisi Alessio, Dell'Amore Andrea, Bertolaccini Luca, Congiu Stefano, Dolci Giampiero, Piccone Giulia, Dal Checco Erika, Stella Franco
Department of CardioThoracic Surgery, S. Orsola Malpighi Hospital, Via Massarenti 9, Bologna, Italy.
Department of Anaesthesiology, S. Orsola Malpighi Hospital, Bologna, Italy.
Gen Thorac Cardiovasc Surg. 2020 Feb;68(2):136-141. doi: 10.1007/s11748-019-01183-7. Epub 2019 Aug 1.
Lung transplantation is nowadays the standard therapy for certain well-defined chronic end-stage lung diseases, even in patients on mechanical ventilation or extracorporeal life support. While these latter techniques have been used worldwide as bridging options to lung transplantation for listed patients, they are not commonly used in previously healthy patients developing acute not-reversible lung failure.
We will discuss two patients without any relevant medical history developing acute lung failure evolving to irreversible acute fibrinous and organising pneumonia (AFOP), thus listed for urgent lung transplantation.
The patients recovered well, and both are still alive.
In the absence of clear guidelines, our approach showed, in these patients, the possible benefits of lung transplantation regarding survival in AFOP.
如今,肺移植是某些明确的慢性终末期肺病的标准治疗方法,即使是对于接受机械通气或体外生命支持的患者也是如此。虽然这些后期技术在全球范围内被用作等待肺移植患者的过渡选择,但它们在既往健康却发生急性不可逆肺衰竭的患者中并不常用。
我们将讨论两名无任何相关病史的患者,他们发生急性肺衰竭并进展为不可逆的急性纤维蛋白性和机化性肺炎(AFOP),因此被列入紧急肺移植名单。
患者恢复良好,两人均存活。
在缺乏明确指南的情况下,我们的方法在这些患者中显示了肺移植在AFOP患者生存方面可能带来的益处。